Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-12-27
1993-06-29
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, 530332, 530345, A61K 3700, A61K 3702
Patent
active
052234886
ABSTRACT:
Presented are an oxidized-type glutathione alkyl ester represented by the formula (I). ##STR1## wherein R denotes a lower alkyl group, and a salt thereof: a method of preparing said ester which is comprised of oxidizing a reduced-type glutathione monoalkyl ester represented by the formula (II), ##STR2## wherein R is as defined above, with the air, hydrogen peroxide or iodine in an aqueous solution: and a pharmaceutical composition and method for suppression of hepatic disorders characterized in that it contains as an active constituent said ester or a pharmaceutically acceptable salt thereof.
REFERENCES:
CA 110: 121380x (1989).
JP Abstract vol. 13 No. 208 (May 16, 1989) of JP 64-26516 (Akira Otsu et al.).
Japanese Unexamined Patent Publication No. 15870/1986 (61-15870).
Isowaki Yuichi
Ogata Kazumi
Sakaue Takahiro
Tsuruoka Hideki
Cashion Jr. Merrell C.
Celsa Bennett M.
Senju Pharmaceutical Company, Ltd.
LandOfFree
Oxidized-type glutathione alkyl ester does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxidized-type glutathione alkyl ester, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidized-type glutathione alkyl ester will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755403